AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cocrystal Pharma, Inc. Director's Dealing 2016

Mar 18, 2016

35066_dirs_2016-03-18_0b656009-5c2a-49b3-98b5-c012e1af288b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2016-03-15

Reporting Person: Rubin Steven D (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-15	Common Stock	P	39216	$0.51	Acquired	733484	Direct

Footnotes

F1: The original Form 4 filed on March 17, 2016 is amended by this Form 4 to correctly reflect the reporting person's amount of securities beneficially owned. No other changes have been made to the original Form 4.